Robert bartlett ecmo. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, Edición 4 - Ebook written by Gail M. Robert bartlett ecmo

 
ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, Edición 4 - Ebook written by Gail MRobert bartlett ecmo  Arensman and others published Extracorporeal Membrane Oxygenation | Find, read and cite all the research you need on ResearchGateDr

We have used extracorporeal membrane oxygenation (ECMO) for 28 patients (14 children and 14 adults) over a 5-year period. Robert Bartlett who first used it in caring for a newborn with meconium aspiration syndrome. ECMO has its highest survival rate among patients with respiratory failure, particularly newborns, reports Dr. University of Michigan Ann Arbor, Ann Arbor, MI, United States. Setting 30 countries across five continents, 3 January 2020 to 29 August 2021. A comparative Trial of ECMO for Neonatal Respiratory Failure in the Netherlands. Now a retired surgeon, Dr. This article was published in Perfusion. ABSTRACT Jugular vein-carotid artery extracorporeal membrane oxygenation. We describe our experience of 30 consecutive children supported with ECMO and receiving 20 ppm of nitric oxide in the oxygenator of the ECMO circuit. PMID: 21177726. Survival ranges from 30% in extracorporeal cardiopulmonary resuscitation to 95% for neonatal meconium aspiration syndrome. Dr Robert Bartlett, who has been called the father of modern extra-corporeal support, made a therapeutic decision in 1975 that brought this technology to neonates with primary respiratory conditions. Gazzaniga and M R Jefferies and Robert F. Her success story was the initiation of ECMO in the neonatal population. For early-adopting centres, the cumulative incidence of in-hospital mortality 90 days after ECMO initiation was 36·9% (95% CI 34·1–39·7) in patients who started ECMO on or before May 1 (group A1) versus 51·9% (50·0–53·8) after May 1. Park. edu. Robert (Bob) Bartlett (born May 8, 1939) is an American physician and medical researcher who is credited with developing a lifesaving heart-lung technology known as extracorporeal membrane oxygenation (ECMO). Over the last 25 years our laboratory research on extracorporeal gas exchange and perfusion (ECMO) has progressed from oxygenator design, through the physiologic response to ECMO, through the developm. Robert Bartlett, Professor Emeritus, Section of General Surgery, Division of Acute Care Surgery, University of Michigan School of Medicine. Ronald Hirschl, Dr. Past, present and future of ECMOThe ratio of oxygen delivery to consumption. Dynamic search and list-building capabilities. Physiology of Extracorporeal Gas Exchange. Research efforts in our laboratory build upon extracorporeal life support (ECLS) technology, including extracorporeal membrane oxygenation, or ECMO, developed nearly 50 years ago by Professor Emeritus Robert H. Gas with a. @article{Bartlett1976ExtracorporealMO, title={Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. There are currently over 70,000 cases in the ELSO Registry. Extracorporeal life support (ECLS) is effective in treating shock status and pulmonary failure. All the gas exchange occurs in the membrane lung, and the arterial oxygenation is the result of mixing the ECMO blood with. Dearborn, Michigan. Research efforts in our laboratory build upon extracorporeal life support (ECLS) technology, including extracorporeal membrane oxygenation, or ECMO, developed nearly 50 years ago by Professor Emeritus Robert H. Join Michigan Medicine ECMO Specialists and Robert Bartlett, M. All ECMO patients should be included in a mobilisation protocol unless there are contraindications, which include hypoxia, hemodynamic instability, unstable cardiac rhythm, intracranial pressure monitoring, lose or unstable cannula sites, desaturation episodes with minimal movements, escalation of vasopressors in the last 12 h, and. Dr. The authors hypothesized that ECMO instituted. When the heart/lung machine is used in the operating room in venoarterial mode to provide total support of heart and lung function to facilitate cardiac operations, the. of treatment. He has undefinable energy. The results. Many ECMO lab alumni have gone on to attend graduate or medical. Bartlett M. Google Scholar. Dr. ECMO is one of several terms used for an extracorporeal circuit that directly oxygenates and removes carbon dioxide from the blood ( Figure 1 ). In 2020, 4812 patients with COVID-19 received ECMO across 349 centres within 41 countries. M. Bartlett supported a 2 year old boy with VA ECMO after cardiac surgery, and Dr. Ogino and Daniel Brodie and D. H. In 1989, the Extracorporeal Life Support. 1. 2021 Aug 10;. Benedikt Treml, 1 Robert Breitkopf, 2 Zoran Bukumiri. 29 patients (15 neonates, seven pediatric, and seven adult patients) with acute. The patient received VA ECMO support for 75 hours, with subsequent decannulation and survival. Go to citation Crossref Google Scholar. and 10,588 adults). MIT engineer Phillip Drinker feeds a dog that lived for four days on an early prototype of the ECMO machine. Robert Bartlett is known around the world as the Father of ECMO for his pioneering work in developing ECMO. Joseph A. Medicine. The "father of ECMO" who pioneered ECMO technology, usage & research. D. Robert Bartlett was on the life-saving team when Hannah Abraham was born and went into severe respiratory distress. Robert H. , William Kennan, M. “It doesn’t treat the patient, but it buys time,” Dr. Dr. ECMO in cardiopulmonary pathophysiology. topics of ferments and germs, disease germs, filth dis-eases, antiseptics and disinfectants and their use, quar-antine and vaccination. Share this grant: : : Abstract; Funding; Institution; Related projects. They discuss the evolu…Robert Bartlett Background: The high-quality evidence on managing COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support is insufficient. Bartlett, Robert H. Robert Bartlett; This is a review of the University of Michigan experience with extracorporeal life support (ECLS) also known as extracorporeal membrane oxygenation (ECMO). In this Q&A, Dr. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Johnny Gray posted images on LinkedIn. In ECMO, thin hollow fiber membranes made up of polymethylpentene act as blood-gas interface for diffusion. ECMO extracorporeal membrane oxygenation, PaO 2 partial pressure of arterial oxygen, FIO 2 fraction of. Deatrick. Robert H. Bartlett, ASAIO Journal, 2016 Mar-Apr; 62(2):. Dr. Robert Bartlett. 4 Modern ECMOs roots, however, are in neonatal critical care whereby Dr Robert Bartlett pioneered its use in pediatric cardiopulmonary failure and published the first randomized controlled trial comparing ECMO. truog@childrens. 6,20 In V-PA ECMO, there is less mixing of. Journals metrics. Find Dr. The same principles apply to the transport of patients with other modes of extracorporeal life support for example, extracorporeal carbon dioxide removal. The first successful use of ECMO in the ICU was reported in a 24-year-old trauma patient who was cannulated due to posttraumatic ARDS. We describe our experience of 30 consecutive children supported with ECMO and receiving 20 ppm of nitric oxide in the oxygenator of the ECMO circuit. . Bartlett, MD. Hirschl is a General Surgeon in Ann Arbor, MI. Carotid arterial access in adults of any age is reasonable. Web Sites. Robert Bartlett, M. Bartlett himself graduated from University of Michigan Medical school in 1963, and was later Professor of Surgery at Michigan. doi: 10. Robert H. Medicine. Director. Design of the prospective controlled randomized study. Robert H. Captain Robert Bartlett found her to be "absolutely unsuitable to remain in winter ice. Institutions (1) 01 Apr 2016-The Egyptian Journal of Critical Care Medicine (No longer published by Elsevier). Web Sites. Nationwide/Regional Organization of ECMO for ARF d ECMO is a high-risk and complex therapy that may be considered for the sickest patients with ARF. C. Compr Physiol 10 : 2020, 879–891. An RCT in the 1970s had shown ECMO not effective for ARDS in adults In the 1980s, Robert Bartlett used ECMO to treat newborns with PPHN Results were very impressive But, pediatricians were reluctant to adopt ECMO without convincing data from an RCT by Joseph B. While heparin bonded circuits have reduced the need for systemic anticoagulation during ECMO, their short half-life limits their efficacy, particularly when the duration of ECMO is extended [4]. The 1990s group were on ECMO for shorter duration, median of 131 h (interquartile range. Robert H. Medical Center Drive, Ann Arbor, MI 48109, USA. Our corporate headquarters, located on East Main Street in Stamford, Connecticut, consists of. Circuit design—Advances in circuit biomaterial composition promise to remove several limitations of contemporary ECMO (Fig. You may opt-out by clicking here. Bartlett shares his thoughts on the FDA’s clearance of Novalung, and how ECMO devices. Refer a Patient. by Julian Walling. D. Joseph A Potkay Alex J Thompson John Toomasian William Lynch Robert H Bartlett Alvaro Rojas-Peña. J. John J. He continued to develop the technology, and the use of ECMO gradually increased from a few cases. Robert E Cilley; Robert Bartlett;. 1177/0885066616641383 Abstract Management of gas exchange using extracorporeal membrane oxygenation (ECMO) in respiratory failure is very different than management when the patient is dependent on mechanical ventilation. Download for offline reading, highlight, bookmark or take notes while you read ECMO:. Development of an artificial placenta V: 70h veno-venous extracorporeal life support after ventilatory failure in premature lambs. ASAIO Journal. Alvaro Rojas, Dr. Robert Bartlett, Professor Emeritus, Section of General Surgery, Division of Acute Care Surgery, University of Michigan School of Medicine. Lynch, Graeme MacLaren, Jay M. Guidance documents addressing additional portions of ECMO care. B. . TLDR. Robert Bartlett needed a way to accurately measure flow in the tubing of his membrane lung. Dysart教授各自分享. Robert H. doi:. Artificial Lung Edwin Sam Robert Bartlett MD Surgeon. (ECMO) technology in 1975. Robert Bartlett who first used it in caring for a newborn with meconium aspiration syndrome. DOI: 10. L'ECMO va ser desenvolupada el 1950 per John Gibbon, i posteriorment per C. Zwischenberger, MD and Robert H. Since 1989, 32,385 neonates required ECMO. "There are plenty of ECMO machines — it's people who know how to run it," says Dr. Indice de Capitulos; Capítulo 1: Historia y desarrollo soporte extracorpóreo; Capítulo 2: Fisiología ECLS; Capítulo 3: Insuficiencia Cardiaca: Principios y fisiología; Capítulo 4: Insuficiencia respiratoria hipoxica aguda en niños; Capítulo 5: Interacción entre la sangre y superficie del biomaterial durante ECLS; Capítulo 6: Registro ELSO; Capítulo 7: Prefacio de las secciones II a. Robert Bartlett successfully treated the first newborn with ECMO o That propelled the neonatal and pediatric use of ECMO o Known as the Father of ECMO What is the difference between ECLS and ECMO? § Extracorporeal life support (ECLS) is the broad umbrella term to describe the entire family of extracorporeal support modalitiesRobert Bartlett; Background: The high-quality evidence on managing COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support is insufficient. Over the past 40 years, the need for ECMO in neonates has decreased due to advances in critical. Robert Bartlett Extracorporeal membrane oxygenation (ECMO) has rescued moribund infants with respiratory failure from a variety of causes. September 28, 2023. George Mychaliska, Dr. PMID: 26201841 DOI: 10. The primary faculty members supporting the lab are Dr. Bartlett. Carotid arterial access scares people, but it is safer than femoral arterial cannulation (personal communication with Dr. Improvements in devices and materials biocompatibility have made ECLS safer and easier in polytrauma. Monitoring of AC therapy under ECMO is recommended and the most common parameter used to assess adequacy of AC therapy in ECMO is activated clotting time (ACT) with a goal range between 180-200. Flow Dynamics of Different Adult ECMO Systems: A Clinical Evaluation. Oxygen and. Advanced management of polytrauma. Lynch, Robert H. Annich, William R. 0000000000000189. TEDxUofM took place April 8th, 2011 at the historic Michigan Theater on the campus of the University of Michigan, Ann Arbor. “The system’s pressure sensor technology ensures continuous monitoring and accurate flow. About ELSO The Extracorporeal Life Support. Nine patients improved on ECMO and 5 were long-term. 6–8,14 As a general guide to practice, we recommend the use of ECMO for patients with COVID-19 and severe cardiopulmonary failure who meet traditional. Oxygen is present in the blood as oxygen dissolved in the plasma and. Electronic address: robert. , Paul Braun, C. We have over one million books available in our catalogue for you to explore. Background To summarize the experience of management of persistent pulmonary hypertension of the newborn (PPHN) with extracorporeal membrane oxygenation (ECMO) support. Didactic Synopsis Major Teaching Points. Is this information wrong?Extracorporeal membrane oxygenation. In the fight to save lives against the coronavirus, Michigan doctors are turning to a last-resort machine. Presented to Extracorporeal Life Support Organization. PDF. Bartlett, University of Michigan, Ann Arbor, Michigan, USA. His exceptional vision, creativity, persistence and resilience has saved countless lives and continues to change the way we treat critically ill patients. History of ECMO. Dr. Dr. This was the baby of a poor immigrant mother from Mexico. •An RCT in the 1970s had shown ECMO not effective for ARDS in adults • In the 1980s, Robert Bartlett used ECMO to treat newborns with PPHN • Results were very impressive • But, pediatricians were reluctant to adopt ECMO without convincing data from an RCTECMO-assisted cardiopulmonary resuscitation in adults. Robert H Bartlett, ECMO Laboratory, B560 MSRB II, 1150 W Medical Center Drive, Ann Arbor; MI 48109, USA. § In 1975, Dr. Jonathan Haft. The medical director of our ECMO Service, Dr. Robert H. Robert Bartlett, MD • Surgeon at University of Michigan Medical Center • Developed of ECMO • Treated first infant in 1975 • 26 research grants including $5 Million from Michigan Critical Care Consultants (MCCC). ECMO support can be provided in three medically refractory circumstances: (1) respiratory failure (3, 4), (2) cardiac failure (5, 6),. Dear Family & Friends,22 Despite adequate systemic oxygenation and CO 2 clearance during V-V ECMO support however, RV injury and occasionally failure may still ensue. Employing new technology, cardiac surgeon Alan B. El 1965, el doctor Robert Bartlett i el seu equip van assolir rescatar un nounat que va aspirar meconi amb aquesta tècnica, marcant l'inici de l'ECMO. • ECMO is necessary in critical care situations when the heart or lungs need help functioning in order to heal. Equation describing the mixing of blood flows of different O2 content. ” Dr Robert Bartlett Because the pandemic is still raging across the country, it will be some time before we fully understand the benefits and outcomes of ECMO for COVID-19 patients. INTRODUCTION. Medical Center Drive, Ann Arbor, MI 48109, USA. 6–8,14 As a general guide to practice, we recommend the use of ECMO for patients with COVID-19 and severe cardiopulmonary failure who meet. Figure 6. Robert Bartlett’s ECMO research lab at the University of California, Irvine, with the original intention to begin using ECMO as a modality for postoperative cardiac patients. B. Currently we average 100+ patients per year. *; Ogino, Mark T. Carotid arterial access scares people, but it is safer than femoral arterial cannulation (personal communication with Dr. Carotid arterial access in adults of any age is reasonable. All the gas exchange occurs in the membrane lung, and the arterial oxygenation is the result of mixing the ECMO blood with the native. columbia. Administration of nitric oxide into the ECMO circuit is safe and could potentially mitigate ischaemia reperfusion injury and end-organ dysfunction of children requiring mechanical support. In 1976, Dr. Bartlett, MD. Accordingly, the study had become a study of early versus late ECMO. 1097/MAT. ECMO Fellowship, Robert Bartlett MD Research Lab University of Michigan, Ann Arbor. In this Classic Papers feature, we highlight Dr. Dr Robert Bartlett; he believes al patients should have a Hgb of 15g/dL. ELSO webinar, moderated by Dr. Robert H. August 25, 2023Robert H. An overview article in Lancet Respiratory Medicine examines the role of ECMO and ECMO centers during the COVID-19 pandemic. A few years later, Robert Bartlett reported the rst infant to bene t from ECMO support. In extracorporeal circulation venous blood is drained from the right atrium, pumped through an artificial lung (membrane oxygenator) and returned to the aorta (venoarterial) or right atrium (venovenous). โรเบิร์ต บาร์ทเลตต์ (Robert Bartlett). He is an emeritus professor of surgery at the University of Michigan Medical School. “A long-term, effective ECMO solution gives critically-ill patients the time and support needed to heal,” said Dr. Robert Bartlett, at the University of Michigan (who also conducted research earlier at the University of California, Irvine), is widely regarded as the founding father of ECMO. Monitoring of AC therapy under ECMO is recommended and the most common parameter used to assess adequacy of AC therapy in ECMO is activated clotting time (ACT) with a goal range between 180-200. It should be emphasized that this initial guidance is based on the current best evidence for ECMO use during this pandemic. When maximal conventional support fails in rescuing sick neonates, extracorporeal membrane oxygenation (ECMO) will be the option in treating reversible respiratory and cardiac pathologies. Learn about the evolution of extracorporeal membrane oxygenation (ECMO) and emerging technologies using ECMO to revolutionize heart and lung failure care, or. Today, many infants who would have been on ECMO in 1995 improve with simpler methods. When the work began, he says, “The heart-lung machine we used for cardiac surgery could support life, but only for a few hours. Bartlett himself graduated from University of Michigan Medical school in 1963, and was. Robert H. Stead and Peter T. Bartlett, ECLS Laboratory, University of Michigan, B560 MSRB II, 1150 W Medical Center Drive, Ann Arbor, MI 48109, USA. Enclosed in this month’s edition of ASAIO Journal, the University of Michigan reports their utilization of extracorporeal membrane oxygenation (ECMO) in more than 2,000 patients over nearly 4 decades. Improvements in devices and materials biocompatibility have made ECLS safer and easier in polytrauma. Currently we average 100+ patients per year. Materials: Cannulas, Pumps, Oxygenators. Felicia Ivascu, received her training at the University of Michigan under the guidance of Dr. As a result of these studies ECLS (also known as extracorporeal membrane oxygenation, ECMO), has been. 3. D. Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure. D. Tota14 statements achieved consensus; included in four domains discussing patient selection, clinical ECMO management, operational and logistic ECMO management and ethics to guide n. Bartlett. Bartlett to the University of Michigan. Veno-venous ECMO has gained popularity in the management of respiratory failure as a way to. Bartlett, MD. D. ELSO was founded in 1989 by Robert H. Sign In. However, using ECMO as “rescue” after other treatments fail results in unnecessary death. Bartlett, Robert H. Epub 2021 Aug 10. The. Bartlett. Published April 23, 2020 at 5:12 PM EDT. In 1975, Dr. 2013 Jan; 48(1): 145-153. Administration of nitric oxide into the ECMO circuit is safe and could potentially mitigate ischaemia reperfusion injury and end-organ dysfunction of children requiring mechanical support. University of Michigan Ann Arbor, Ann Arbor, MI, United States. Robert Bartlett, Dr. Robert H. hdb5@cumc. Robert Bartlett. Griffith, MD, from the University of Pittsburgh, visited Dr. Author Information . }, author={Robert H. . Theodor Kolobow. Schreiner, MD Flow. 0000000000001223. Robert Bartlett). . {Robert H. Bartlett. Disclaimer: ECMO has, and will certainly continue, to play a role in the management of COVID-19 patients. continued conventional management in critically ill patients would be unethical due to the fact that those randomized to the non-ECMO arm would have higher. Bartlett, then working at the University of California at Irvine, reported his first neonatal ECMO survivor. Robert H. Contra-indications. Wilson, Robert H. 0000000000000697. Decades ago, U-M's Dr. 1097/MAT. Today, Esperanza Pineda is 44. A pioneer in the field of neonatal critical care, Dr. We applied a multivariable Cox model to examine whether patient and hospital factors were associated with in-hospital mortality. Critical Care Medicine. An ECMO machine consists of a pump with an oxygenator that replaces the function of the heart and lung, respectively. Projects Awarded $3. Bartlett, MD and Joseph B. As I reread this article today, I am struck by issues of time warp. The more I learn about ECMO Specialists the more I am convinced they are true superheroes! 🦸‍♂️ Here is why: 1. Bartlett, MD, who is credited with developing extracorporeal membrane oxygenation (ECMO) in the 1960s and ’70s. ECMO – or extracorporeal membrane oxygenation, the most extreme form of life support – is typically considered only for an average of fewer than 10 days, as a last. Bartlett}, journal={Journal of Intensive Care Medicine}, year={2017}, volume={32}, pages={243 -. ECMO technology was developed in the late 1960s by a team led by Robert H. continued conventional management in critically ill patients would be unethical due to the fact that those randomized to the non-ECMO arm would have higher. D. ECMO support has been evaluated in 29 newborn infants with respiratory failure and lung function improved in 16 and 13 surivived, indicating improvement in lung function. 1971:Dr J. Pearl O'Rourke comments on how Dr Bartlett changed the face of critical care and how the report of his first 28 cases affected her clinical practice and research. Abstract. In 1972 Robert Bartlett and Alain Gazzaniga at the University of California in Irvine first successfully used cardiac ECMO in a two-year-old infant with cardiac failure after an operative correction of transposition of the great vessels (Mustard procedure), followed by a report of a growing series of children supported by ECMO after congenital. 2 “Such a tribute is true to his humble style; however, those who know Bob realize he exudes much more than an. 1097/MAT. (venoarterial [VA] ECMO) or a vein (venovenous [VV] ECMO). To manage patients on ECMO, it is essential to understand the physiology described in this essay, which includes the role of gas exchange in the membrane lung and the arterial oxygenation. Robert H. Study with Quizlet and memorize flashcards containing terms like Dr. 1997; 25 (1):28–32. Explore the tabs below to learn more about Bartlett's expert staff. Bartlett and Conrad 5) SA explained the ratio logically. Robert Bartlett & Matt Paden, highlighting the current research underway focused on better understanding the impact of COVID-19, and the role of extracorporeal support and ICU care in patients with SARS-CoV-2 Coronavirus infection. com, Elsevier’s leading platform of peer-reviewed scholarly literature. Extracorporeal membrane oxygenation (ECMO) provides temporary pulmonary and/or cardiac support when medical management fails or when the degree of support required is considered injurious to the patient (1, 2). Vascular access can be obtained using the Crescent™ Dual Lumen Catheter. Extracorporeal Membrane Oxygenation for Neibom Respiratory Failze Thomas R. 3,4 By the early 1980s, ECMO was more widely used in theAlthough the maximum ECMO duration is not defined, 9–13 the duration of ECMO support has increased with the development of biocompatible materials, miniaturization of the ECMO system, and a better understanding of ECMO support. Three years after the onset of COVID-19, our understanding of the role of ECMO has evolved. ECMO in the ICU The SWAC ELSO experience - SWAC ELSO 2016 (SWAC ELSO 2016) Edited by Dr Malaika Mendonca. Föreläsning på Karolinska universitetssjukhuset med dr Robert Bartlett, University of Michigan, om behandlingsmetoden Ecmo. Dr. Play over 320 million tracks for free on SoundCloud. M. Earlier trials with ECMO support demonstrated improved survival in infantsThe use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, although there is controversy regarding the evidence justifying its use (1–9). A case of COVID-19 was defined ECMO was made possible by Bartlett’s previous research with sheep, and he and his colleagues have continued to improve it by testing new ideas in animals. Shock. Bishoy Zakhary Education Committee . Dr. PMID:. Author Information . Robert Bartlett - Top podcast episodes Listen Later API Data2020 Sep/Oct;66 (9):975-979. Pediatric Extra. Bartlett was Director of the Surgical Intensive Care Unit, Program Director of the Surgical. 1997; 25 (1):28–32. Candis Jones & Robert Bartlett) by TSRA Podcast on desktop and mobile. Our first patient was in 1981, with a total of eight patients that year. In this fashion each patient is truly randomly assignedElectracorporeal membrane oxygenation is now used in several neonatal centers as the treatment of choice for full-term infants with respiratory failure that is unresponsive to conventional management. In extracorporeal circulation venous blood is drained from the right atrium, pumped through an artificial lung (membrane oxygenator) and returned to the aorta (venoarterial) or right atrium. In 1980 to 1981, 1 of the 6 patients (17%) who were eligible for ECMO by criteria of Bartlett et al survived, which is consistent with the published data. Annich, William R. Potential indications for the use of ECMO include severe ARF from: severe ARDS, status asthmaticus, bridge to lung transplantation, post lung transplantation. Dr. Robert Bartlett, will be delivering a special keynote address. PowerPoint presentation on Extracorporeal Membrane Oxygenation (ECMO)-Focuses mainly on evolution of ECMO, Types, Indications, Veno-venous V/S veno-Arterial ECMO, Cannulation and Circuit. Robert Bartlett who first used it in caring for a newborn with meconium aspiration syndrome. Journal of Medical Biography 2014 24: 3, 371-376 Download Citation. The November–December 2017 issue of ASAIO Journal is home to five manuscripts on extracorporeal membrane oxygenation (ECMO). Oxygen delivery (DO 2) is the amount of oxygen delivered to the peripheral tissues per minute, or the product of arterial oxygen content (CO 2) times the cardiac output. Bartlett proved instrumental in the creation and advancement of ECMO treatment. Medical Center Drive, B560 MSRB II, ann rbor, MI. Contact 2? Contact 3? Contact 4? See All Contacts.